- Home
- IOSP vs NAMS Comparison
IOSP vs NAMS Comparison
Compare IOSP & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOSP
- NAMS
- Stock Information
- Founded
- IOSP 1938
- NAMS 2019
- Country
- IOSP United States
- NAMS Netherlands
- Employees
- IOSP N/A
- NAMS N/A
- Industry
- IOSP Major Chemicals
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- IOSP Industrials
- NAMS Health Care
- Exchange
- IOSP Nasdaq
- NAMS Nasdaq
- Market Cap
- IOSP 2.2B
- NAMS 2.2B
- IPO Year
- IOSP 1998
- NAMS N/A
- Fundamental
- Price
- IOSP $84.73
- NAMS $18.19
- Analyst Decision
- IOSP Strong Buy
- NAMS Strong Buy
- Analyst Count
- IOSP 1
- NAMS 6
- Target Price
- IOSP $155.00
- NAMS $42.83
- AVG Volume (30 Days)
- IOSP 171.0K
- NAMS 694.5K
- Earning Date
- IOSP 05-08-2025
- NAMS 05-08-2025
- Dividend Yield
- IOSP 1.92%
- NAMS N/A
- EPS Growth
- IOSP N/A
- NAMS N/A
- EPS
- IOSP 1.08
- NAMS N/A
- Revenue
- IOSP $1,786,000,000.00
- NAMS $47,140,000.00
- Revenue This Year
- IOSP $0.74
- NAMS N/A
- Revenue Next Year
- IOSP $7.75
- NAMS N/A
- P/E Ratio
- IOSP $78.62
- NAMS N/A
- Revenue Growth
- IOSP N/A
- NAMS 586.97
- 52 Week Low
- IOSP $80.32
- NAMS $14.06
- 52 Week High
- IOSP $133.53
- NAMS $27.29
- Technical
- Relative Strength Index (RSI)
- IOSP 38.06
- NAMS 48.96
- Support Level
- IOSP $84.70
- NAMS $16.95
- Resistance Level
- IOSP $87.94
- NAMS $19.58
- Average True Range (ATR)
- IOSP 2.15
- NAMS 0.93
- MACD
- IOSP -0.26
- NAMS -0.07
- Stochastic Oscillator
- IOSP 8.91
- NAMS 51.69
About IOSP Innospec Inc.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Fuel Specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field service providers in the extraction of oil and gas. The Performance Chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.